Home > Boards > US OTC > Biotechs >

Tauriga Sciences, Inc. (TAUG)

Add TAUG Price Alert      Hide Sticky   Hide Intro
Moderator: diannedawn, $Pistol Pete$, U GOT TRUMPED
Search This Board: 
Last Post: 2/19/2018 9:12:34 AM - Followers: 321 - Board type: Free - Posts Today: 6

Welcome to Tauriga Sciences, Inc. (TAUG) Board!!!



Tauriga Sciences, Inc. (TAUG) is a diversified life sciences company focused on generating profitable revenues in the natural wellness sector and on developing a proprietary synthetic biology platform technology through its wholly-owned Pilus Energy subsidiary.

The Company's business model is to create an attractive and balanced portfolio of life sciences assets without typical clinical regulatory timelines.

TAUG Security Details
Share Structure
  Market Value1 $9,421,817 a/o Apr 27, 2016
  Authorized Shares 2,500,000,000 a/o Jan 07, 2016
  Outstanding Shares 1,326,270,933 a/o June 08, 2016
  -Restricted Not Available
  -Unrestricted Not Available
  Held at DTC Not Available
  Float 433,764,438 a/o Jul 17, 2014
  Par Value  



Headlines Get Headlines for: 

Wednesday, April 20, 2016

Monday, April 18, 2016

Friday, April 15, 2016

Tuesday, April 12, 2016

Wednesday, April 6, 2016

Tuesday, March 22, 2016

Tuesday, March 8, 2016

Friday, February 5, 2016



Management is firmly committed to building lasting shareholder value in the short, intermediate, and long terms. 

Seth M. Shaw 
CEO / Chairman

Mr. Shaw has extensive experience building companies and securing financing from a broad range of both domestic and international institutional investors. Over the past seven years, he has been instrumental in securing more than $60 million in capital, in aggregate, for several small-cap and micro-cap companies. Mr. Shaw started his career at American International Group (AIG) Global Investment Group, after which he gained further experience working at a prestigious Manhattan based hedge fund. In 2005, he founded Novastar Resources Ltd, a natural resources exploration company focused on the exploration and acquisition of mineral properties containing the element thorium. During this period, Mr. Shaw secured more than $17 million in financing from top tier institutional investors and helped complete the merger between Novastar Resources and Thorium Power, holding the position of Director of Strategic Planning until mid-2007. Subsequently, the company changed its name to Lightbridge Inc. and currently trades on the NASDAQ (LTBR). Following the merger, Mr. Shaw has assisted several other companies in securing value added capital from institutional investors as well as providing management consulting services. Among those, Mr. Shaw was instrumental in securing $12,000,000 for NASDAQ listed flat panel display developer Uni-Pixel Inc. (UNXL). In addition Mr. Shaw served as the founding CFO of Los Angeles based Biotech firm Physician Therapeutics LLC (“PTL”) in 2004. Subsequently PTL merged with Targeted Medical Pharma (“TMP”), which announced plans for a $118 million NASDAQ IPO in February of 2011. Mr. Shaw graduated from Cornell University in 2001, with a degree in Policy Analysis Management and a concentration in Econometrics. Mr. Shaw currently serves on the Board of Directors of the Jewish Community Center (JCC) of Dutchess County (New York) and has been active in numerous charities and not for profits, including: The Robinhood Foundation (2007-2009), The Cypress Fund for World Peace and Security (2006-2010), and Save A Child’s Heart (“SACH”).

Ghalia Lahlou 
Interim CFO

Ms. Lahlou joined Tauriga Sciences, Inc. in May 2011 as the Operations Manager based in the Montreal office. She previously worked in a number of operational roles ranging from the energy sector to healthcare. Ms. Lahlou was pivotal in interfacing and managing institutional and high net worth investors during her tenure with two early stage public companies. Prior to this, she served the role of assistant project manager at one of the largest steel manufacturing companies in North Africa. During her time there, she played a key role in the development of new product lines catering to the construction and building sector. At Tauriga Sciences, her role involves maintaining relationships with investors, managing daily operations and overseeing company communications with the investor community and the regulatory authorities in U.S and Canada. Ms. Lahlou graduated from McGill University, Montreal, Canada with a degree in Mechanical Engineering. Prior to that, she completed her studies in Health Sciences at Marianopolis College, Montreal.





Cody Harrison, VP & General Manager, Pilus Energy

Cody graduated from Duke University’s Nicholas School of the Environment in 2012, where he earned a Bachelor of Arts degree in Environmental Science and Policy with an emphasis on the methods and motivations of Sustainable Development. During his time at Duke he received interdisciplinary training in entrepreneurship, energy, sociology, biotechnology, ecology, and engineering. His goal is to work toward the humane application of technology for the restoration, and then preservation, of the natural environment and humankind.

Cody first heard about Pilus Energy toward the end of his sophomore year at Duke. His interest in synthetic biology and renewable energy, plus the potential for immense social and environmental benefit led him to seek a license to the Company’s developing intellectual property. His focus was on remediating swine waste. This is a significantly serious problem in North Carolina, particularly the eastern part of the state where Concentrated Animal Feeding Operations (CAFOs) are commonplace. Cody thought that due to state legislation requiring an increasing amount of electricity to come from swine waste every year Pilus’s technology might be the golden ticket to solve this problem. Unfortunately Pilus still required a pilot scale project before deployment. Upon graduation, Pilus Energy’s President, Jason E. Barkeloo, impressed with Cody’s impassioned entrepreneurial approach, intellectual capacity, and self-directed learning, recruited Cody.

Cody began by leading the Company’s business development, pilot management, and engineering support. After the Company was acquired in January of 2014 by Tauriga Sciences, he was appointed to General Manager of Pilus Energy.



google plus+:


Contact Us: 1-917-796-9926 |
twitter:"" rel="nofollow" target="_blank">; target="_blank" rel="nofollow">


"Pilus Energy's interdisciplinary team has a sense of urgency to provide a profitable wastewater-to-value solution. By extracting energy from molecular compounds in waste water, adopters of our technology will generate revenues while reducing risks.

Whether your wastes are by-products of manufacturing, food processing, sanitation, or recalled products, it is likely we can help you extract value from the values stored in those wastes.

Some value-added opportunities include carbon and renewable energy credits (RECs), remediation and odor control, energy production, biogas production, and reduction of pathogens. If you are seeking to reduce your carbon footprint while maximizing your economic gain, talk to us. We can likely scale a solution for you...."


Pilus Mitochondrion Whitepaper.PDF




• Daniel J. Hassett, PhD, 
co-Founder and Chair, Scientific Advisory Board

Currently a fully tenured professor of molecular genetics, biochemistry, and microbiology at the University of Cincinnati, College of Medicine. Dr. Hassett is an award-winning expert on cystic fibrosis, particularly as it relates to infectious microorganism. He is a frequent invited speaker, convener, and symposia presenter with over ninety scientific events thus far. He has participated in the thesis defense and/or doctoral exams for nearly thirty graduate students. Dr. Hassett manages a lab and has gained over $15M in grants and donations as a research leader.

He is a journal reviewer for the following 17 journals (in alphabetic order): Applied and Environmental Microbiology, Cell-Host and Microbe, Free Radical Biology and Medicine, Gene, Infection and Immunity, Journal of Bacteriology, Journal of Biological Chemistry, Journal of Clinical Investigation, Letters in Applied Microbiology, Microbial Pathogenesis, Microbiology, Molecular Microbiology, Plant-Microbe Interactions, PloS Medicine, Proceedings of the National Academy of Sciences, Science, Trends in Microbiology Reviews.

His intellectual property developments include: 1. Streaking Jack Inoculator. A device that isolates single bacterial colonies from a mixed population in 5 seconds. With U.C. and Bell-Art Scientific. 2. OprF, a biomarker for cystic fibrosis lung disease and an anaerobic drug target. 3. Use of nitrite composition to kill pathogenic bacteria during airway and abscess infections. Aires Pharmaceuticals, San Diego, CA, November 2006, Toxicology completed, 8-07; Phase I human trials completed August 2008. Phase II trials-anticipated start, October 2008.

He has over one hundred cited journal articles and conference proceedings including:

  1. Yoon, S.S., R.F. Hennigan, G.M. Hilliard, U.A. Ochsner, K. Parvatiyar, M.C. Kamani, H.L. Allen, T.R. DeKievit, P.R. Gardner, U. Schwab, J.J. Rowe, B.H. Iglewski, T.R. McDermott, R.P. Mason, D.J. Wozniak, R.E.W. Hancock, M.R. Parsek, T.L. Noah, R.C. Boucher and D.J. Hassett. 2002. Pseudomonas aeruginosa Anaerobic Respiration in Biofilms: Relationships to Cystic Fibrosis Pathogenesis. Dev. Cell 3: 631-642.
    Ran, D.J. Hassett and G.W. Lau. 2003. Eukaryotic targets of the Pseudomonas aeruginosa virulence factor pyocyanin. Proc. Natl. Acad. Sci. 100: 14315-14320.
    Yoon, S.S., R. Coakley, G.W. Lau, S.V. Lymar, A.C. Karabulut, R.F. Hennigan, S.H. Hwang, B. Gaston, G. Buettner, M.J. Schurr, J.E. Mortensen, J.L. Burns, D. Speert, R.C. Boucher and D.J. Hassett. 2006. Anaerobic Killing of Mucoid Pseudomonas aeruginosa With Acidified Nitrite Derivitives Under Cystic Fibrosis Airway Conditions. J. Clin. Invest. 116: 436-446.
    Yoon, S.S., R.F. Hennigan, A.B. Herr, S.L. Groce, E. Munck, J.D. Lipscomb, A.K. Carabulet, P.J. Kiley, S.H. Hwang, M.J. Schurr, and D.J. Hassett. 2007. Two-Pronged Survival Strategy for the Major Cystic Fibrosis Pathogen, Pseudomonas aeruginosa, Lacking the Capacity to Degrade Nitric Oxide During Anaerobic Respiration. EMBO J. 26: 3662-3672.
    Conrady D.G., Brescia, C.C., Horii, K., Weiss, A.A., Hassett, D.J., and Herr, A.B. 2008. A zinc-dependent adhesion module is responsible for intercellular adhesion in staphylococcal biofilms. Proc. Natl. Acad. Sci.105:19456-61.

• Randy T. Irvin, PhD, co-Founder and Pilus Consultant

Currently is a fully tenured Professor of Medical Microbiology and Immunology in the Faculty of Medicine and Dentistry at the University of Alberta, Edmonton, Alberta, Canada. Dr. Irvin is internationally recognized for his work on Pseudomonas aeruginosa, particularly the structure and function of the pilus and its role in pathogenesis and biofilm formation. Dr. Irvin has served as past President of the Canadian Society of Microbiologists, as a section Editor for the Canadian Journal of Microbiology, and currently sits on the Scientific Advisory Board of Helix BioPharma Corp. Dr. Irvin has served, and continues to serve, as a reviewer for a variety of academic journals, and granting agencies including the Canadian Institutes for Health Research, Natural Sciences and Engineering Research Council of Canada, and National Institutes of Health. Dr. Irvin received over $15M in grants and research contracts.

Dr. Irvin has been involved with a number of biotech companies in a number of projects. Dr. Irvin is an inventor on 30 patents that covering a variety of applications including synthetic vaccines, carbohydrate based therapeutics, synthetic combinatorial peptide libraries, biosensors, and biofilms.

Selected publications

Hazes, B., P.A. Sastry, K. Hayakawa, R.J. Read, and R.T. Irvin. 2000. Crystal structure of Pseudomonas aeruginosa PAK pilin suggests a mainchain-dominated mode of receptor binding. J. Mol. Biol. 299: 1005-1017.

Keizer, D.W., C.M. Slupsky, M. Kalisiak, A.P. Campbell, M.P. Crump, P.A. Sastry, B. Hazes, R.T. Irvin, and B.D. Sykes. 2001. Structure of a pilin monomer from Pseudomonas aeruginosa: implications for the assembly of pili. J. Biological Chemistry 276:24186-24193.

Audette, G.F., R.T. Irvin and B. Hazes. 2004. Crystallographic analysis of the Pseudomonas aeruginosa strain K122-4 monomeric pilin reveals a conserved receptor binding architecture. Biochemistry 43:11427-11435.

Audette, G.F., E. van Schaik, B. Hazes and R.T. Irvin. 2004. DNA-Binding Protein Nanotubes: Learning From Nature’s Nanotech Examples. Nano Lett. 4: 1897-1902. DOI: 10.1021/nl048942f .

Van Schaik, E.J., C.L. Giltner, G.F. Audette, D.W. Keizer, D.L. Bautista, C.M. Slupsky, B.D. Sykes, and R.T. Irvin. 2005. DNA binding: a novel function of Pseudomonas aeruginosa type IV pili. J. Bacteriol. 187:1455-1464.

Giltner, C.L., E.J. van Schaik, G.F. Audette, D. Kao, R.S. Hodges, D.J. Hassett, and R. T. Irvin. 2006. The Pseudomonas aeruginosa Type IV Pilin Receptor Binding Domain Functions as an Adhesin for Binding to Both Biotic and Abiotic Surfaces. Molec. Microbiol. 59:1083–1096. published online early December 12,2005 doi:10.1111/j.1365-2958.2005.05002.x.

Kao, D.J., E.A.M. Churchill, R.T. Irvin, and R.S. Hodges. 2007. Animal protection and structural studies of a consensus sequence vaccine targeting the receptor binding domain of the type IV pilus of Pseudomonas aeruginosa. J. Mol. Biol. 374(2):426-42.

Yu, B., C.L. Giltner, E.J. van Schaik, D.L. Bautista, R.S. Hodges, G.F. Audette, D.Y. Li, and R.T. Irvin. 2007. A novel biometallic interface: high affinity tip-associated binding by pilin-derived protein nanotubes. J. Bionanosci. 1:73–83.

• R. Everett Langford, PhD, Environmental Engineering Advisor

Dr. Roland Everett Langford has almost 40 years experience in environmental protection, occupational safety and health, and radiation protection. He holds Ph.D. degrees in Physical Chemistry from the University of Georgia with a minor in Geology and in Radiation Health Physics from the University of North Carolina at Chapel Hill with a minor in Industrial Hygiene, as well as a Masters degree (M.S.) in thermodynamics from the University of Georgia. In addition to academic degrees, he is a Certified Industrial Hygienist (CIH), a Certified Safety Professional (CSP), a licensed Professional Engineer (PE) in the State of Texas, a Certified Professional Environmental Auditor (CPEA), a Fellow of the American Institute of Chemists, a Diplomate of the American Academy of Sanitarians (DAAS), a Registered Hazardous Materials Professional (RHSP), and a registered Sanitarian (RS). Dr. Langford is the author or co-author of three books (on Hazardous Materials Incidents, Workplace Drug Abuse, and Weapons of Mass Destruction). He served for twenty years in the U.S. Army Medical Department, retiring in the rank of Lieutenant Colonel, following command of the Army Research Detachment for Toxicology of the Walter Reed Army Institute of Research. He has worked in industry for over ten years, and has international work experience in Bosnia, Croatia, Korea, and Peoples Republic of China. Prior to his military career, he was a college professor of chemistry and geology. Dr. Langford’s hobbies include Asian studies, photography, and amateur (ham) radio.

His certifications include: •Certified Industrial Hygienist (CIH), American Board of Industrial Hygiene, Comprehensive Practice, Number 3284.

•Certified Safety Professional (CSP), Board of Certified Safety Professionals, Number 15180.

•Certified Professional Environmental Auditor (CPEA), Board of Environmental, Health and Safety Auditors Certifications (BEAC), Number 513.

•Professional Engineer (PE), General Engineering Sciences, State of Texas, Number 96365.

•Registered Hazardous Substances Professional (RHSP), National Environmental Health Association, Number 51.

•Registered Sanitarian (RS), National Environmental Health Association, Number 83277.

Selected publications include:

R.E. Langford, “Applications of Methylene Diphenyl Diisocyanate,” presented as part of Professional Development Course 412 (“Isocyanates: Current Issues in Toxicology, Occupational Medicine, Industrial Hygiene, and Regulation”) at the American Industrial Hygiene Conference, Toronto, Ontario, Canada, May 31, 2009.

R.E. Langford, “ERPGs as Community Exposure Standards,” presented at Gulf Coast Chapter of the American Industrial Hygiene Association, Houston, TX, January 15, 2009.

R.E. Langford, “Incorporating EHS into Project Management,” presented at JW Pearson 2nd Annual Process Industry Engineering Conference, Shanghai, Peoples Republic of China, November 28, 2007.

R.E. Langford, “Community Exposure Standards,” presented at Association of International Chemical Manufacturers Conference on Hazardous Materials, Shanghai, Peoples Republic of China, May 21, 2007.

R.E. Langford, “New Chinese Regulations on Production of Phosgene,” presented at International Isocyanates Institute Phosgene Conference, Xi’An, Peoples Republic of China, May 15, 2007.

R.E. Langford, Introduction to Weapons of Mass Destruction: Radiological, Biological, and Chemical; Wiley-Interscience Publishers (2004), ISBN 0-471-46560-7.

• Jeffrey D. Myers, MS, co-Founder and Fuel Cell Consultant

Jeff graduated from The Ohio State University with Honors and Distinction, obtaining B.S. and M.S. degrees in Mechanical Engineering. As a Principal Research Scientist at Battelle he led research projects developing environmental monitoring systems. His professional career focused on leading research programs utilizing a variety of control, measurement systems and data processing techniques including those employed in environmental monitoring, homeland defense, and energy systems. He has experience in program management, sensor/monitor design, opto-mechanical systems, computer programming, and data collection. His primary interests in the application of technology to improve the human condition. In nearly twenty years at Battelle he gained experience in leading engineers and scientists in efforts to develop and implement sensor, control systems and fuel cells. Jeff received and managed over $10M in research awards.

Kelly, T.J., Myers, J.D., and Spicer, C.W., “Evaluation of an Electrochemical Method for Continuous Indoor Monitoring of NO2 and Nitrous Acid”, in Measurement of Toxic and Related Air Pollutants, Proceedings of the 1998 EPA/AWMA International Symposium, Publication VIP-85, Air and Waste Management Association, Pittsburgh, PA, pp. 615-620 (1998).

Kelly, T.J., and Myers, J.D., “Development of a Short-Averaging-Time Indoor Nitrogen Dioxide Detector”, Final Report to the California Air Resources Board, Contract No. 96-312, Battelle, Columbus, Ohio, December, 1999.

Kelly, T.J., Myers, J.D., and Holdren, M.W., “Testing of Household Products and Materials for Emission of Toluene Diisocyanate”, Indoor Air, 9, 117-124 (1999).

Myers, J.D., “Optical Sensor Used to Evaluated Spark Ignition and Combustion of Methane”, M.S. Thesis, The Ohio State University, 1994.

M.C. Hastings, B.N. Chiu, and J.D. Myers, “Evaluation of Special Communications Grade Fibers in Interferometric and Microbend Sensors for Measuring Ambient Temperature Fluctuations”, Proceedings of the SPIE, Vol. 1795, pp. 227-235 (1993).

Jeff is the first author or co-author of 8 Technology Verification Reports on environmental monitoring systems, published from testing in the Advanced Monitoring Systems (AMS) Center of U.S. EPA’s Environmental Technology Verification (ETV) Program at:

Open-Path Optical Monitors:

  • AIL Systems Inc. RAM 2000 Fourier Transform Infrared, September 2000
    Boreal Laser Inc. GasFinder 2.0 Tunable Diode Laser, September 2000
    Opsis Inc. AR 500 Ultraviolet Open-Path Monitor, September 2000
    Unisearch Associates LasIR® Tunable Diode Laser, September 2000
    Spectrex SafEye 227 Infrared, March 2001
    Spectrex SafEye 420 Ultraviolet, March 2001
    Mercury Continuous Emission Monitors
    Lumex Ltd. Hg CEM, September 2001
    Multi-Metals Continuous Emission Monitor
    Cooper Environmental Services XCEM

• Warunya Panmanee, PhD, Microbiology and Genetics Consultant

Microbiology and Genetics Consultant

Dr. Panmanee as a member of Dr. Hassett’s team, she is responsible for our microbial colony reproduction and development. She is currently a Research Associate, Department of Molecular Genetics, Biochemistry and Microbiology, College of Medicine, at the University of Cincinnati. Previously, she was a post-doctoral fellow at the Laboratory of Biotechnology, Chulabhorn Research Institute, Bangkok, Thailand. She completed a BS at Prince of Songkla University, Songkla, Thailand. Her MS and PhD were earned at Mahidol University, Bangkok, Thailand.

Her publications include:

Panmanee W, Vattanaviboon P, Pool L.B, and Mongkolsuk S. 2006 Novel organic hydroperoxide-sensing and responding mechanisms for OhrR, a major Bacterial Sensor and regulator of organic hydroperoxide stress. J Bacteriol. 188(4):13899-95

Newberry KJ, Fuangthong M, Panmanee W, Mongkolsuk S, Brennan RG. 2007 Structural mechanism of organic hydroperoxide induction of the transcription regulator OhrR. Mol Cell.30;28(4):652-64

Panmanee W, Gomez F, Witte D, Pancholi V, Britigan BE, Hassett DJ. 2008. The peptidoglycan-associated lipoprotein OprL helps protect a Pseudomonas aeruginosa mutant devoid of the transactivator OxyR from hydrogen peroxide-mediated killing during planktonic and biofilm culture J. Bacteriol. 90(10):3658-69

Panmanee W and Hassett DJ. 2009 Differential roles of oxyR-controlled antioxidant enzymes alkyl hydroperoxidase reductase (AhpCF) and catalase (KatB) in protection of Pseudomonas aeruginosa against hydrogen peroxide in biofilm versus planktonic culture. FEMS Microbiol. Lett, 295 : 238-244.

Wilson, J.J., B. Homoelle, W. Panmanee, D.J. Hassett and R.A. Kovall. 2010. One protein, two structures: structural and biophysical characterization of Pseudomonas aeruginosa AnkB. Biochemistry. (submitted).

Major, T.A., W. Panmanee, J.E. Mortensen, L.D. Gray, and D.J. Hassett. 2010. Sodium Nitrite-Mediated Killing of Pseudomonas aeruginosa, Staphylococcus aureus and Burkholderia cepacia Under Anaerobic Conditions is Synergistic With Antibiotics Used for Treating Cystic Fibrosis Airway Infections. Antimicrob. Agents Chemother. (submitted).

S. Su, W. Panmanee, J.J. Wilson, J.D. Lipscomb, S.H. Kim, S.V. Lymar, R.A. Kovall, R.T. Irvin, Y.H. Cho, and D.J. Hassett. 2010. The Pseudomonas aeruginosa Constitutively Expressed Catalase KatA Protects Bacteria From Potentially Lethal Levels of Nitric Oxide Generated During Anaerobic Respiration. Proc. Natl. Acad. Sci. (in preparation).

Panmanee, W., Mahavihakanont A, Rattanaprapanporn S, Whiteside M, Brinkman F , Mongkolsuk S and Hassett DJ. 2010 2-aminoethylphosphonate:pyruvate aminotransferase: an alternative means to protect a Pseudomonas aeruginosa oxyR mutant from tert-butyl hydroperoxide. In preparation

Panmanee W., Mahavihakanont A, Rattanaprapanporn S, Sauer K, Whiteside M, Brinkman F, Mongkolsuk S and Hassett DJ. 2010 Reciprocal Regulation of Oxidative Stress and Quorum Sensing/Biofilm Dispersion Regulatory Networks During Pseudomonas aeruginosa Biofilm Dispersion In preparation.

Chris Bordeaux, MBA, Hydrogen Business Advisor
• Tim Ferguson, Energy Business Advisor
• Peter J. Moriarty, Biotechnology Business Advisor



FREE 72 pg. Executive Informational Overview on Tauriga Sciences, Inc. - By Crystal Research Associates, LLC 

* The Corporate Snapshot was last updated on September 16, 2014.

Letter of Support from Metropolitan Sewer District of Greater Cincinnati

U.S. PATENT # 8,354,267

Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
TAUG News: Current Report Filing (8-k) 02/16/2018 01:43:14 PM
TAUG News: Quarterly Report (10-q) 02/12/2018 05:01:59 PM
TAUG News: Current Report Filing (8-k) 01/04/2018 01:20:34 PM
TAUG News: Current Report Filing (8-k) 12/22/2017 09:01:54 AM
TAUG News: Current Report Filing (8-k) 12/15/2017 02:38:45 PM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
#44645  Sticky Note $TAUG Tauriga Sciences Inc. Gains Exposure to Electric $Pistol Pete$ 02/17/18 02:32:02 PM
#43662  Sticky Note Tauriga Sciences, Inc. Establishes Wholly Owned Subsidiary to U GOT TRUMPED 01/04/18 11:40:08 AM
#43500  Sticky Note For newcomers here who are probably not aware... diannedawn 12/27/17 04:41:37 PM
#44661   "Questionable crypto currency announcements" Is that what the PR skidoo31 02/19/18 09:12:34 AM
#44660   I wouldn't worry about comparing TAUG to what's skidoo31 02/19/18 09:10:25 AM
#44659   "So I then typed in and am loanranger 02/19/18 07:50:14 AM
#44658   I searched under tauriga sciences on google and johnny8544 02/19/18 04:05:16 AM
#44657   I am not making any contention. All I johnny8544 02/19/18 02:23:01 AM
#44656   It would be impossible for me to change johnny8544 02/19/18 02:17:38 AM
#44655   is your contention, that Tauriga will be suspended??? clearmont88 02/18/18 02:01:08 PM
#44654   Do a little research, none of those companies skidoo31 02/18/18 12:34:22 PM
#44653   "A quick look at three stocks temporarily suspended vinovista 02/18/18 12:31:55 PM
#44652   ""Three tiny stocks with same CEO suspended by skidoo31 02/18/18 04:00:41 AM
#44651   FACT; SEC SUSPENDS 3 PENNY STOCKS WITH johnny8544 02/18/18 02:01:52 AM
#44650   The consultant still has not listed even one johnny8544 02/18/18 01:33:47 AM
#44649   I think Tauriga's goal is to enhance its clearmont88 02/17/18 04:08:10 PM
#44648   Hhmmmm....Nobody is being paid to post anything diannedawn 02/17/18 04:07:59 PM
#44647   REALLY????I think when the test run in stores occurs diannedawn 02/17/18 03:53:46 PM
#44646   Nobody stated there are guarantees as to the Johnny_C 02/17/18 02:46:44 PM
#44645   $TAUG Tauriga Sciences Inc. Gains Exposure to Electric $Pistol Pete$ 02/17/18 02:32:02 PM
#44644   WE NOW KNOW THAT THE TAUG PAID CONSULTANT'S rawman 02/17/18 11:38:25 AM
#44643   TAUG's December 31, 2017 CASH BALANCE was just rawman 02/17/18 11:08:55 AM
#44642   Now that we know that the investment was rawman 02/17/18 10:38:42 AM
#44641  Restored I think you underestimate the potential TAUG has rawman 02/17/18 10:22:23 AM
#44640  Restored I think there is a distribution channel...[ rawman 02/17/18 10:03:44 AM
#44639   VTGN could have opted to have their warrants rawman 02/17/18 09:51:29 AM
#44638  Restored Again, if the common shares are sold TAUG rawman 02/17/18 09:44:16 AM
#44637   Based on a number of posts over the rawman 02/17/18 09:33:16 AM
#44636   I appreciate the correction and have been SLOWLY loanranger 02/17/18 07:47:46 AM
#44635   I think you underestimate the potential TAUG has Johnny_C 02/17/18 04:56:57 AM
#44634   Again I ask that you list even 20 johnny8544 02/16/18 08:24:31 PM
#44633   No, Keith will make the DECN story real. DrZem 02/16/18 07:30:32 PM
#44628   Kind of the like every story about DECN ksviking12 02/16/18 05:43:24 PM
#44627   I think there is a distribution channel and Johnny_C 02/16/18 04:09:34 PM
#44626   It says nothing, except he is asking who Johnny_C 02/16/18 04:03:39 PM
#44625   No it is not....Give it a break Johnny_C 02/16/18 03:50:58 PM
#44624   This was the post zoran 02/16/18 03:46:44 PM
#44622   Makes total sense...a Gotcha moment!! zoran 02/16/18 03:34:48 PM
#44621   That does not even make sense at all Johnny_C 02/16/18 03:33:01 PM
#44620   Too late for damage control zoran 02/16/18 03:29:45 PM
#44619   The warrants have value now....Again, you just have Johnny_C 02/16/18 03:26:46 PM
#44618   Nobody is being paid to post anything. If Johnny_C 02/16/18 03:22:34 PM
#44615   What about the other 2 that aren't being zoran 02/16/18 03:12:58 PM
#44613   I think TAUG is pretty close to even Johnny_C 02/16/18 03:02:16 PM
#44612   More wasted investment. He didn’t learn from letsmakemoney0001 02/16/18 02:54:59 PM
#44611   Again, if the common shares are sold TAUG Johnny_C 02/16/18 02:53:52 PM
#44607   can sell the stock and hold the warrants...risk free rawman 02/16/18 01:13:52 PM
#44605   can sell the stock and hold the warrants...risk free Johnny_C 02/16/18 01:04:04 PM
#44603   You have to be concerned any time anyone rawman 02/16/18 12:50:07 PM
#44602   Plus it is virtually a risk free investment rawman 02/16/18 12:43:24 PM
#44601   You have to be concerned any time anyone gman3 02/16/18 12:38:55 PM
#44600   I think when the test run in stores Johnny_C 02/16/18 12:20:37 PM
#44599   Do you understand trials have phases? Johnny_C 02/16/18 12:17:30 PM